- Home
- MAX vs SANA Comparison
MAX vs SANA Comparison
Compare MAX & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MAX | SANA |
|---|---|---|
| Founded | 2014 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 732.5M | 793.1M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MAX | SANA |
|---|---|---|
| Price | $12.86 | $3.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $12.70 | $7.80 |
| AVG Volume (30 Days) | 731.5K | ★ 2.5M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.81 | 17.24 |
| EPS | ★ 0.86 | N/A |
| Revenue | ★ $1,113,600,000.00 | N/A |
| Revenue This Year | $13.42 | N/A |
| Revenue Next Year | $8.16 | N/A |
| P/E Ratio | $15.31 | ★ N/A |
| Revenue Growth | ★ 28.78 | N/A |
| 52 Week Low | $7.09 | $2.61 |
| 52 Week High | $14.70 | $6.55 |
Technical Indicators
Market Signals| Indicator | MAX | SANA |
|---|---|---|
| Relative Strength Index (RSI) | 49.46 | 60.15 |
| Support Level | $12.74 | $3.82 |
| Resistance Level | $14.32 | $4.28 |
| Average True Range (ATR) | 0.60 | 0.24 |
| MACD | -0.05 | 0.04 |
| Stochastic Oscillator | 55.25 | 76.97 |
Price Performance
Historical ComparisonAbout MAX MediaAlpha Inc.
MediaAlpha Inc provides a platform that enables insurance carriers and distributors to target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It serves as a customer acquisition channel in property and casualty insurance, health insurance, and life insurance. The company operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.